These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 26138225)

  • 1. Tedizolid Adsorption and Transmembrane Clearance during in vitro Continuous Renal Replacement Therapy.
    Lewis SJ; Switaj LA; Mueller BA
    Blood Purif; 2015; 40(1):66-71. PubMed ID: 26138225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ertapenem clearance during modeled continuous renal replacement therapy.
    Stevenson JM; Patel JH; Churchwell MD; Vilay AM; Depestel DD; Sörgel F; Kinzig M; Jakob V; Mueller BA
    Int J Artif Organs; 2008 Dec; 31(12):1027-34. PubMed ID: 19115194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ex vivo Rezafungin Adsorption and Clearance During Continuous Renal Replacement Therapy.
    Jang SM; Hough G; Mueller BA
    Blood Purif; 2018; 46(3):214-219. PubMed ID: 30048960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal hemodiafilter performance in modeled continuous renal replacement therapy.
    Pasko DA; Churchwell MD; Salama NN; Mueller BA
    Blood Purif; 2011; 32(2):82-8. PubMed ID: 21372565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telavancin and hydroxy propyl-beta-cyclodextrin clearance during continuous renal replacement therapy: an in vitro study.
    Patel JH; Churchwell MD; Seroogy JD; Barriere SL; Grio M; Mueller B
    Int J Artif Organs; 2009 Oct; 32(10):745-51. PubMed ID: 19943236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and dialytic clearance of apixaban during in vitro continuous renal replacement therapy.
    Andrews L; Benken S; Tan X; Wenzler E
    BMC Nephrol; 2021 Jan; 22(1):45. PubMed ID: 33516188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adsorption and Clearance of the Novel Fluorescent Tracer Agent MB-102 During Continuous Renal Replacement Therapy: In Vitro Results.
    Jang SM; Shieh JJ; Riley IR; Dorshow RB; Mueller BA
    ASAIO J; 2023 Jul; 69(7):702-707. PubMed ID: 37071749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of vancomycin clearance by continuous venovenous hemofiltration and continuous venovenous hemodialysis.
    Joy MS; Matzke GR; Frye RF; Palevsky PM
    Am J Kidney Dis; 1998 Jun; 31(6):1019-27. PubMed ID: 9631848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of solute clearance in three modes of continuous renal replacement therapy.
    Parakininkas D; Greenbaum LA
    Pediatr Crit Care Med; 2004 May; 5(3):269-74. PubMed ID: 15115566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ex vivo Ceftolozane/Tazobactam Clearance during Continuous Renal Replacement Therapy.
    Chaijamorn W; Shaw AR; Lewis SJ; Mueller BA
    Blood Purif; 2017; 44(1):16-23. PubMed ID: 28237981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effects of dialysate and ultrafiltration flow rate on solute clearance during continuous renal replacement therapy].
    Gong D; Ji D; Xie H; Xu B; Liu Y; Li L
    Zhonghua Nei Ke Za Zhi; 2001 Mar; 40(3):183-6. PubMed ID: 11798577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trimethoprim and sulfamethoxazole transmembrane clearance during modeled continuous renal replacement therapy.
    Kesner JM; Yardman-Frank JM; Mercier RC; Wong CS; Walker SE; Argyres DP; Vilay AM
    Blood Purif; 2014; 38(3-4):195-202. PubMed ID: 25531772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imipenem/Relebactam Ex Vivo Clearance during Continuous Renal Replacement Therapy.
    Jang SM; Yessayan L; Dean M; Costello G; Katwaru R; Mueller BA
    Antibiotics (Basel); 2021 Sep; 10(10):. PubMed ID: 34680765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acetaminophen clearance during ex vivo continuous renal replacement therapies.
    Scoville BA; Vulaj V; Mueller BA; Annich GM; Wagner DS
    J Artif Organs; 2018 Jun; 21(2):215-219. PubMed ID: 29063343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Daptomycin clearance during modeled continuous renal replacement therapy.
    Churchwell MD; Pasko DA; Mueller BA
    Blood Purif; 2006; 24(5-6):548-54. PubMed ID: 17124423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cefepime and continuous renal replacement therapy (CRRT): in vitro permeability of two CRRT membranes and pharmacokinetics in four critically ill patients.
    Isla A; Gascón AR; Maynar J; Arzuaga A; Toral D; Pedraz JL
    Clin Ther; 2005 May; 27(5):599-608. PubMed ID: 15978309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo evaluation of enoxaparin removal by continuous renal replacement therapies with acrylonitrile and polysulfone membranes.
    Isla A; Gascón AR; Maynar J; Arzuaga A; Corral E; Martín A; Solinís MA; Muñoz JL
    Clin Ther; 2005 Sep; 27(9):1444-51. PubMed ID: 16291417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CVVHD treatment with CARPEDIEM: small solute clearance at different blood and dialysate flows with three different surface area filter configurations.
    Lorenzin A; Garzotto F; Alghisi A; Neri M; Galeano D; Aresu S; Pani A; Vidal E; Ricci Z; Murer L; Goldstein SL; Ronco C
    Pediatr Nephrol; 2016 Oct; 31(10):1659-65. PubMed ID: 27139897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine removal during continuous renal replacement therapy: an ex vivo comparison of convection and diffusion.
    Cole L; Bellomo R; Davenport P; Tipping P; Ronco C
    Int J Artif Organs; 2004 May; 27(5):388-97. PubMed ID: 15202816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor necrosis factor-alpha during continuous high-flux hemodialysis in sepsis with acute renal failure.
    Lonnemann G; Bechstein M; Linnenweber S; Burg M; Koch KM
    Kidney Int Suppl; 1999 Nov; (72):S84-7. PubMed ID: 10560813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.